RetinaLyze® is a screening software that revolutionizes eye care by helping professionals detect and prevent eye diseases in a safe and efficient manner. With an automated algorithm powered by artificial intelligence (AI), this software analyzes retinal images to identify signs of eye diseases. It can be utilized as a clinical decision support system (CDSS) or as a screening tool alongside the telemedicine module.

RetinaLyze® aims to simplify eye testing worldwide, preventing tragic consequences due to delayed treatment of retinal lesions. As a registered company in Denmark, RetinaLyze® provides AI services specifically designed for the Optometry and Healthcare industry. This innovative software enables retailers to offer healthcare-related services rapidly, regardless of their employees' level of education and experience.

By embracing AI, businesses can disrupt the market and provide consistent healthcare services without the need for extensive educational programs. RetinaLyze® offers expert guidance and support in implementing this cutting-edge technology, as well as education, technology, marketing, and benchmarking assistance